Altach funding news – Healthtech Startup Altach Raises €1.2Million in Fresh Funding

The money came from a number of sources, including two individual angel investors, NLC's Stepping Stone Fund, Castanjo B.V., and a crowdsourcing effort on Spark crowdsourcing.

Jola Danaj, Investment Manager at NLC said, "The goal of NLC Health Ventures is to increase everyone's access to healthcare. "It's scaffolds represent a significant leap forward in the ability to treat cartilage lesions, By eliminating the need for intrusive procedures, this device lowers healthcare expenses while also improving patient outcomes. As Altach moves closer to clinical testing and potential commercialization, we are thrilled to support them."

The money will go towards advancing it's technology towards commercialization, which will ultimately aid patients suffering from cartilage damage.

Read also - Powall funding news – Dutch-based Powall Secures €3Million in Funding

CEO Kosowski, says, “Our technology marks a significant advancement in how we treat articular cartilage injuries. Our scaffolds could reduce recovery times and increase the quality of healing, profoundly improving patients’ daily lives.”

The goal of NLC Health Ventures is to increase everyone's access to healthcare. By using a scalable entrepreneurial methodology, it finds, develops, and supports projects that could help patients.

About Altach

Established in 2022 as a spin-out from Trinity College Dublin, it was founded by David Browe and Tomir Kosowski with the goal of addressing one of the most difficult orthopaedic challenges.

Altach is a venture business under NLC. Becoming the industry leader in regenerative cartilage technology is their mission at Altach. Their goal is to develop a portfolio of biomimetic cartilage grafts that will enable physicians to correct cartilage abnormalities and improve patients' quality of life.